The global vascular embolization devices market at a CAGR of almost 6% during the forecast period

Wednesday, December 11, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 11, 2019 /PRNewswire/ --

Global Vascular Embolization Devices Market: About this market This vascular embolization devices market analysis considers sales from both coiling and non-coiling devices. Our study also finds the sales of vascular embolization devices in Asia, Europe, North America, and ROW. In 2019, the coiling segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing prevalence of cancer and vascular diseases will play a significant role in the coiling segment to maintain its market position. Also, our global vascular embolization devices market report looks at factors such as increasing prevalence of vascular diseases, rising number of new product launches, and growing number of M&A activities. However, high costs associated with embolization procedures, frequent product recalls, and stringent regulations and complications associated with embolization procedures may hamper the growth of the vascular embolization devices industry over the forecast period.

Read the full report:

Global Vascular Embolization Devices Market: Overview Rising number of new product launches Healthcare equipment manufacturers are exploring the potential opportunities to convert the increased demand for medical devices into a continuous cycle of innovation and improvisation for enhanced products. Vendors in the market are launching an array of new product lines to offer better options to buyers. In addition, key players in the market are developing new coils with various technological innovations. Thus, increasing product launches coupled with rising technological innovations in the device designing process will lead to the expansion of the global vascular embolization devices market at a CAGR of almost 6% during the forecast period. Innovations in embolization products and procedures Technological advancements and innovations in embolization devices have increased their adoption in the treatment of chronic conditions such as cancer and neurovascular diseases. Innovations in vascular embolization devices, including coils, particles, plugs, and liquid embolic, have enables physicians to perform embolization procedures with more ease and accuracy, which has driven the demand for vascular embolization devices. The embolic agents, developed by scientists at the University of Minnesota, are made of organic materials, which degrade at a controlled rate and are reabsorbed by the body. Another innovative advancement noted in the market is microvascular plugs, which can be used in microcatheters. This development is expected to have a positive impact on the overall market growth. Competitive Landscape With the presence of several major players, the global vascular embolization devices market is fragmented. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vascular embolization devices manufacturers, that include Abbott Laboratories, Boston Scientific Corp., Cook Group, Johnson & Johnson Services Inc., Medtronic Plc, Merit Medical Systems Inc., Penumbra Inc., Shape Memory Medical Inc., Stryker Corp., and Terumo Corp. Also, the vascular embolization devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Diabetes Premium Membership Benefits

News A - Z



Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store